[ Price : $8.95]
Pfizer says the pivotal Phase 3 CREST trial of sasanlimab in combination with standard of care met its primary endpoint as an indu...[ Price : $8.95]
J&J reports data from the Phase 2b SunRISe-1 study evaluating TAR-200, an intravesical gemcitabine releasing system, for patients ...[ Price : $8.95]
Novavax and HHS clarify that FDA is requesting a post-approval study and not a clinical trial that must be conducted prior to appr...[ Price : $8.95]
Medtronic files a PMA for its Hugo robotic-assisted surgery system for a urologic indication.[ Price : $8.95]
FDA clears BlackfinBio to conduct a Phase 1/2 clinical trial of its novel adeno-associated virus gene therapy, BFB-101, in childre...[ Price : $8.95]
FDA issues Telix Pharmaceuticals a complete response letter on its NDA for Pixclara (floretyrosine F18), a positron emission tomog...[ Price : $8.95]
FDA issues a clinical hold on VYNE Therapeutics Phase 1b study evaluating VYN202 for treating moderate-to-severe plaque psoriasis ...[ Price : $8.95]
HHS secretary Robert F. Kennedy Jr. vows to restore FDAs and other health agencies Freedom of Information Act (FOIA) offices that ...